Wang F - Search Results

1

Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis.

Wang F, He MM, Yao YC, Zhao X, Wang ZQ, Jin Y, Luo HY, Li JB, Wang FH, Qiu MZ, Lv ZD, Wang DS, Li YH, Zhang DS, Xu RH. Wang F, et al. Among authors: wang ds, wang fh, wang zq. Cell Rep Med. 2021 Aug 27;2(9):100383. doi: 10.1016/j.xcrm.2021.100383. eCollection 2021 Sep 21. Cell Rep Med. 2021. PMID: 34622226 Free PMC article. Clinical Trial.

2

[Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].

Zhang DS, Jiang WQ, Li S, Zhang XS, Mao H, Chen XQ, Li YH, Zhan J, Wang FH. Zhang DS, et al. Ai Zheng. 2003 Aug;22(8):870-3. Ai Zheng. 2003. PMID: 12917038 Chinese.

3

[Clinical analysis of 59 cases of primary gastric non-Hodgkin's lymphoma].

He YF, Li YH, Huang HQ, Xia ZJ, Sun XF, Lin TY, Lin XB, Yuan ZY, Li ZM, Wang FH, Wang SS, Jiang WQ. He YF, et al. Ai Zheng. 2005 Apr;24(4):475-7. Ai Zheng. 2005. PMID: 15820073 Chinese.

4

[Clinical analysis of liver damage of 116 malignant lymphoma patients with chronic HBV infection after cytotoxic chemotherapy].

Li YH, He YF, Wang FH, Lin XB, Xia ZJ, Sun XF, Lin TY, Huang HQ, Zhang L, Xu RH, Jiang WQ, Guan ZZ. Li YH, et al. Ai Zheng. 2005 Dec;24(12):1507-9. Ai Zheng. 2005. PMID: 16351802 Chinese.

5

[Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].

Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ. Huang HQ, et al. Ai Zheng. 2006 Apr;25(4):486-9. Ai Zheng. 2006. PMID: 16613686 Chinese.

6

[Efficacy of rituximab-containing regimens on indolent B-cell lymphoma--a report of 34 cases].

Xia ZJ, Wang FH, Huang HQ, Luo HY, Li YH, Lin TY, Jiang WQ, Guan ZZ. Xia ZJ, et al. Ai Zheng. 2006 Apr;25(4):490-4. Ai Zheng. 2006. PMID: 16613687 Chinese.

7

[Phase I clinical trial of intravenous recombinant human lymphotoxin-alpha derivative].

Wang FH, Li YH, Li S, Jiang WQ, Guan ZZ. Wang FH, et al. Ai Zheng. 2006 Apr;25(4):501-4. Ai Zheng. 2006. PMID: 16613689 Clinical Trial. Chinese.

8

[Clinical pharmacokinetic trial of intravenous injection of recombinant human lymphotoxin-alpha derivative].

Li S, Wang FH, Liao H, Li YH, Jiang WQ, Guan ZZ. Li S, et al. Ai Zheng. 2006 Dec;25(12):1524-8. Ai Zheng. 2006. PMID: 17166379 Chinese.

9

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Li YH, Wang FH, Jiang WQ, Xiang XJ, Deng YM, Hu GQ, Xu DM, Chen Y, Lin Q, He YJ. Li YH, et al. Cancer Chemother Pharmacol. 2008 Aug;62(3):539-44. doi: 10.1007/s00280-007-0641-2. Epub 2008 Jan 3. Cancer Chemother Pharmacol. 2008. PMID: 18172651 Clinical Trial.

10

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.

He YF, Li YH, Wang FH, Jiang WQ, Xu RH, Sun XF, Xia ZJ, Huang HQ, Lin TY, Zhang L, Bao SP, He YJ, Guan ZZ. He YF, et al. Ann Hematol. 2008 Jun;87(6):481-5. doi: 10.1007/s00277-008-0454-3. Epub 2008 Feb 26. Ann Hematol. 2008. PMID: 18299831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,782 results

Search Page

Filters